Tag: VARIPURE
J&J highlights favourable 12-month interim results on Varipulse platform at EHRA 2026
Johnson & Johnson (J&J) has announced favourable 12-month interim effectiveness and safety results from VARIPURE—the largest prospective post-market follow-up study evaluating first-time pulsed field ablation...
J&J announces European launch of Varipulse Pro following CE-mark approval
Johnson & Johnson (J&J) has announced the launch of Varipulse Pro in Europe following CE-mark approval, advancing its pulsed field ablation (PFA) portfolio with...
J&J unveils real-world results from VARIPURE substudy at ESC 2025
Johnson & Johnson (J&J) MedTech has today announced acute safety and effectiveness results from the VARIPURE substudy of the SECURE study evaluating the company’s Varipulse...
J&J MedTech presents new Omny-IRE and VARIPURE study data at HRS...
Johnson & Johnson (J&J) MedTech has announced positive initial three-month results from the Omny-IRE study evaluating the investigational Omnypulse platform in patients with paroxysmal...